Interferon-associated combined branch retinal artery and central retinal vein obstruction.
Rubio
Juan E
JE
Charles Retina Institute, Memphis, Tenessee, USA. jirubio@sbcglobal.net
Charles
Steve
S
D000998:Antiviral Agents / Q000009:adverse effects*; D005451:Fluorescein Angiography; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D015356:Retinal Artery Occlusion / Q000139:chemically induced* / Q000175:diagnosis; D012170:Retinal Vein Occlusion / Q000139:chemically induced* / Q000175:diagnosis
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a